GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,084,000 | +159.2% | 89,339 | +21.6% | 0.01% | +200.0% |
| Q2 2022 | $2,347,000 | +4.3% | 73,445 | +13.0% | 0.00% | 0.0% |
| Q1 2022 | $2,251,000 | +21.9% | 64,979 | +3.0% | 0.00% | +50.0% |
| Q4 2021 | $1,847,000 | +15.3% | 63,103 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $1,602,000 | -25.0% | 62,867 | +3.1% | 0.00% | -33.3% |
| Q2 2021 | $2,136,000 | -13.0% | 60,990 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $2,454,000 | -10.9% | 60,233 | -5.2% | 0.00% | -25.0% |
| Q4 2020 | $2,753,000 | -24.5% | 63,557 | -3.9% | 0.00% | -33.3% |
| Q3 2020 | $3,647,000 | -17.3% | 66,133 | -5.4% | 0.01% | -14.3% |
| Q2 2020 | $4,411,000 | +1.5% | 69,872 | -17.9% | 0.01% | -22.2% |
| Q1 2020 | $4,347,000 | -33.6% | 85,087 | +3.3% | 0.01% | -18.2% |
| Q4 2019 | $6,546,000 | +72.0% | 82,344 | +5.0% | 0.01% | +57.1% |
| Q3 2019 | $3,805,000 | -7.0% | 78,420 | +0.9% | 0.01% | -12.5% |
| Q2 2019 | $4,090,000 | +9.6% | 77,749 | +10.2% | 0.01% | +14.3% |
| Q1 2019 | $3,733,000 | +36.8% | 70,529 | +6.1% | 0.01% | +16.7% |
| Q4 2018 | $2,729,000 | +58.9% | 66,481 | +47.2% | 0.01% | +100.0% |
| Q3 2018 | $1,717,000 | -21.9% | 45,179 | -7.1% | 0.00% | -25.0% |
| Q2 2018 | $2,198,000 | +26.4% | 48,618 | +35.1% | 0.00% | 0.0% |
| Q1 2018 | $1,739,000 | +19.4% | 35,996 | -2.7% | 0.00% | +33.3% |
| Q4 2017 | $1,456,000 | +9.7% | 37,010 | -13.4% | 0.00% | 0.0% |
| Q3 2017 | $1,327,000 | +16.1% | 42,741 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $1,143,000 | +62.1% | 41,801 | +118.5% | 0.00% | +50.0% |
| Q1 2017 | $705,000 | +186.6% | 19,131 | +12.3% | 0.00% | +100.0% |
| Q4 2016 | $246,000 | -17.2% | 17,042 | +32.3% | 0.00% | 0.0% |
| Q3 2016 | $297,000 | +53.1% | 12,886 | +10.4% | 0.00% | 0.0% |
| Q2 2016 | $194,000 | -4.0% | 11,671 | +86.6% | 0.00% | 0.0% |
| Q4 2015 | $202,000 | – | 6,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |